Civic Data
FDA RecallsUSDA RecallsAbout

FDA Recalls

  • Food recalls
  • Drug recalls
  • Device recalls

USDA Recalls

  • All USDA recalls
  • Poultry recalls
  • Meat recalls
  • Egg recalls

About

  • About us
  • FDA guides
  • USDA guides
  • Data sources
  • Privacy policy

Data

  • OpenFDA API
  • USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

  1. FDA Recalls
  2. ›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification
AllClass IClass IIClass III
Status
AllOngoingCompletedTerminated
Date
All timePast 30 daysPast 12 months

Showing 561–580 of 1,000 recalls

Class IIITerminated

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.

Mylan Pharmaceuticals Inc.

Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

August 27, 2018 · DrugView details →
Class IIITerminated

MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03

Jubilant Cadista Pharmaceuticals, Inc.

Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.

August 27, 2018 · DrugView details →
Class IIITerminated

Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01

LUPIN SOMERSET

Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.

August 23, 2018 · DrugView details →
Class IIITerminated

Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.

Mayne Pharma Inc

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

August 21, 2018 · DrugView details →
Class IIITerminated

Valsartan Tablets USP, 320 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-363-90

Jubilant Cadista Pharmaceuticals, Inc.

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

August 14, 2018 · DrugView details →
Class IIITerminated

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

August 14, 2018 · DrugView details →
Class IIITerminated

Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30

Jubilant Cadista Pharmaceuticals, Inc.

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

August 14, 2018 · DrugView details →
Class IIITerminated

Valsartan Tablets USP, 80 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-361-90

Jubilant Cadista Pharmaceuticals, Inc.

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

August 14, 2018 · DrugView details →
Class IIITerminated

Valsartan Tablets USP, 160 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-362-90

Jubilant Cadista Pharmaceuticals, Inc.

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

August 14, 2018 · DrugView details →
Class IIITerminated

Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709

United Therapeutics Corp.

Defective Delivery System: Water ingress through the lower water cup sensor of the device.

August 14, 2018 · DrugView details →
Class IIITerminated

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Orexigen Therapeutics, Inc.

Defective Container: Customer complaints of punctures in the bottle.

August 9, 2018 · DrugView details →
Class IIITerminated

Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle per box, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-718-10

Akorn, Inc.

Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide

August 8, 2018 · DrugView details →
Class IIITerminated

Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01

Mylan Pharmaceuticals Inc.

Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

August 7, 2018 · DrugView details →
Class IIITerminated

Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-05

Mylan Pharmaceuticals Inc.

Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

August 7, 2018 · DrugView details →
Class IIITerminated

Well at Walgreens, Scar Cream with SPF 30, (Avobenzone 3%, Octocrylene 10%, Oxybenzone 6%), 0.7 OZ (19.8 g) tube, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, UPC 3 11917 18281 0.

Product Quest Manufacturing LLC

Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.

August 3, 2018 · DrugView details →
Class IIITerminated

Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma Lab USA Inc., Houston, TX 77027, UPC 6 50067 00018 7.

Product Quest Manufacturing LLC

Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.

August 3, 2018 · DrugView details →
Class IIITerminated

Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Distributed by: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320, NDC 71537-001-02

Huijing (Shanghai) Bio-tech Co., Ltd.

Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.

August 3, 2018 · DrugView details →
Class IIITerminated

Atorvastatin Calcium tablets, 40 mg, 500-count bottle, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 India, NDC 55111-123-05

Dr. Reddy's Laboratories, Inc.

Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.

August 2, 2018 · DrugView details →
Class IIITerminated

Levofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-046-24.

Baxter Healthcare Corporation

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

August 1, 2018 · DrugView details →
Class IIITerminated

Levofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-048-24.

Baxter Healthcare Corporation

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

August 1, 2018 · DrugView details →
← PreviousPage 29 of 50Next →